Weekly paclitaxel in heavily pretreated ovarian cancer patients: does this treatment still provide further advantages?

被引：0
|
作者：
GianMaria Miolo
Ettore Bidoli
Davide Lombardi
Davide Adriano Santeufemia
Giampiero Capobianco
Francesco Dessole
Simona Scalone
Simon Spazzapan
Roberto Sorio
Gianna Tabaro
Andrea Veronesi
机构：
[1] Centro di Riferimento Oncologico,Department of Oncology, Division of Medical Oncology C
[2] National Cancer Institute,Epidemiology and Biostatistics Unit
[3] Centro di Riferimento Oncologico,Department of Oncology, Division of Medical Oncology
[4] National Cancer Institute,undefined
[5] Pordenone Hospital,undefined
[6] Gynecologic and Obstetric Clinic,undefined
[7] University of Sassari,undefined
来源：
Archives of Gynecology and Obstetrics | 2012年 / 285卷
关键词：
Chemotherapy; Dose density; Ovarian carcinoma; Weekly paclitaxel;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：499 / 503
页数：4
相关论文
共 50 条
  • [1] Weekly paclitaxel in heavily pretreated ovarian cancer patients: does this treatment still provide further advantages?
    Miolo, GianMaria
    Bidoli, Ettore
    Lombardi, Davide
    Santeufemia, Davide Adriano
    Capobianco, Giampiero
    Dessole, Francesco
    Scalone, Simona
    Spazzapan, Simon
    Sorio, Roberto
    Tabaro, Gianna
    Veronesi, Andrea
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 285 (02) : 499 - 503
  • [2] Chronic administration of single weekly paclitaxel in heavily pretreated ovarian cancer patients
    Yamamoto, K
    Oogi, S
    Inoue, H
    Kudoh, K
    Kita, T
    Kikuchi, Y
    CURRENT MEDICINAL CHEMISTRY, 2004, 11 (04) : 425 - 428
  • [3] THE EFFECT OF SINGLE WEEKLY PACLITAXEL IN HEAVILY PRETREATED OVARIAN CANCER PATIENTS AND ITS ANTIANGIOGENIC EFFECTS
    Kikuchi, Yoshihiro
    Kita, Tsunekazu
    Takano, Masashi
    Kudoh, Kazuya
    Saito, Keiko
    Fujii, Kazuyuki
    Sasaki, Naoki
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3535 - 3535
  • [4] The effect of single weekly paclitaxel in heavily pretreated patients with recurrent or persistent advanced ovarian cancer
    Kita, T
    Kikuchi, Y
    Takano, M
    Suzuki, M
    Oowada, M
    Konno, R
    Yamamoto, K
    Inoue, H
    Seto, H
    Yamamoto, T
    Shimizu, K
    GYNECOLOGIC ONCOLOGY, 2004, 92 (03) : 813 - 818
  • [5] The effect of single weekly paclitaxel in heavily pretreated ovarian cancer patients and its antiangiogenic effects.
    Kudoh, K
    Kikuchi, Y
    Kita, T
    Takano, M
    Saito, K
    Fujii, K
    Sasaki, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 483S - 483S
  • [6] Phase I study with weekly Paclitaxel (1 H) infusion in heavily pretreated advanced breast cancer and ovarian cancer patients
    Klaassen, U
    Wilke, H
    Strumberg, D
    Eberhardt, W
    Korn, M
    Seeber, S
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 380 - 380
  • [7] Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancer
    Klaassen, U
    Wilke, H
    Strumberg, D
    Eberhardt, W
    Korn, M
    Seeber, S
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (03) : 547 - 549
  • [8] Platelet-sparing effect of paclitaxel in heavily pretreated ovarian cancer patients
    Ishikawa H.
    Fujiwara K.
    Suzuki S.
    Tanaka Y.
    Kohno I.
    International Journal of Clinical Oncology, 2002, 7 (5) : 330 - 333
  • [9] Effect of weekly administration of bevacizumab, gemcitabine, and oxaliplatin in patients with heavily pretreated ovarian cancer
    Ikeda, Yuji
    Kikuchi, Yoshihiro
    Takano, Masashi
    Goto, Tomoko
    Kouta, Hiroko
    Sasaki, Naoki
    Kudoh, Kazuya
    Oda, Katsutoshi
    Nagasaka, Tsuneki
    Kita, Tsunekazu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Efficacy and safety of weekly paclitaxel in elderly patients with heavily pretreated platinum-resistant ovarian carcinoma.
    Sanchez-Bayona, Rodrigo
    Tolosa, Pablo
    Sanchez de Torre, Ana
    Castelo, Alicia
    Bernal-Hertfelder, Elsa
    Lema, Laura
    Ciruelos, Eva M.
    Manso, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345